IL17A and psoriasis: In a mouse model of imiquimod-induced psoriasis-like skin lesions, apigenin decreased erythema, scaling, and Psoriasis Area and Severity Index (PASI) score, and it also inhibited NF-kB activation and the IL-23/STAT3/IL-17A pathway [154].